Skip to content
10-Q

Quarterly Report

iTeos Therapeutics, Inc.

0000950170-25-103529

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 30, 2025 44.21M sh
Shares Diluted Q2 2025 · Jun 30, 2025 43.56M sh
Shares Diluted Q2 2025 · Jun 30, 2025 43.4M sh
Shares Diluted Q2 2025 · Jun 30, 2024 39.7M sh
Shares Diluted Q2 2025 · Jun 30, 2024 37.77M sh
Capex Q2 2025 · Jun 30, 2025 $384K
Capex Q2 2025 · Jun 30, 2024 $1.39M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$76.21M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$66.33M
Short Term Investments Q2 2025 · Jun 30, 2025 $307.61M
Short Term Investments Q2 2025 · Dec 31, 2024 $352.52M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $207.82M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $142.13M
Stockholders Equity Q2 2025 · Jun 30, 2025 $493.8M
Stockholders Equity Q2 2025 · Mar 31, 2025 $563.42M
Stockholders Equity Q2 2025 · Dec 31, 2024 $590.29M
Stockholders Equity Q2 2025 · Jun 30, 2024 $663.87M
Stockholders Equity Q2 2025 · Mar 31, 2024 $541.2M
Stockholders Equity Q2 2025 · Dec 31, 2023 $575.23M
Current Liabilities Q2 2025 · Jun 30, 2025 $70.27M
Current Liabilities Q2 2025 · Dec 31, 2024 $40.36M
Total Liabilities Q2 2025 · Jun 30, 2025 $129.28M
Total Liabilities Q2 2025 · Dec 31, 2024 $96.68M
Current Assets Q2 2025 · Jun 30, 2025 $528.99M
Current Assets Q2 2025 · Dec 31, 2024 $509.54M
Total Assets Q2 2025 · Jun 30, 2025 $623.08M
Total Assets Q2 2025 · Dec 31, 2024 $686.98M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.81
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.61
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.18
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.20
Eps Basic Q2 2025 · Jun 30, 2025 −$1.81
Eps Basic Q2 2025 · Jun 30, 2025 −$2.61
Eps Basic Q2 2025 · Jun 30, 2024 −$0.18
Eps Basic Q2 2025 · Jun 30, 2024 −$1.20
Sga Expense Q2 2025 · Jun 30, 2025 $10.18M
Sga Expense Q2 2025 · Jun 30, 2025 $21.16M
Sga Expense Q2 2025 · Jun 30, 2024 $12.46M
Sga Expense Q2 2025 · Jun 30, 2024 $25.16M
Rd Expense Q2 2025 · Jun 30, 2025 $57.28M
Rd Expense Q2 2025 · Jun 30, 2025 $86.31M
Rd Expense Q2 2025 · Jun 30, 2024 $36.71M
Rd Expense Q2 2025 · Jun 30, 2024 $71.24M
Net Income Q2 2025 · Jun 30, 2025 −$78.73M
Net Income Q2 2025 · Jun 30, 2025 −$113.34M
Net Income Q2 2025 · Mar 31, 2025 −$34.61M
Net Income Q2 2025 · Jun 30, 2024 −$7.13M
Net Income Q2 2025 · Jun 30, 2024 −$45.34M
Net Income Q2 2025 · Mar 31, 2024 −$38.22M
Operating Income Q2 2025 · Jun 30, 2025 −$83.79M
Operating Income Q2 2025 · Jun 30, 2025 −$123.81M
Operating Income Q2 2025 · Jun 30, 2024 −$14.17M
Operating Income Q2 2025 · Jun 30, 2024 −$61.4M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $35M
Revenue Q2 2025 · Jun 30, 2024 $35M